Market Cap | ₹3,90,348Cr |
ROE | 15.13% |
P/E Ratio(TTM) | 37.63 |
EPS(TTM) | 43.23 |
P/B Ratio | 5.41 |
Dividend Yield | 0.98% |
Industry P/E | 35.19 |
Book Value | 300.99 |
Debt to Equity | 0.03 |
Face Value | 1 |
Parent Organisation | Sun Pharmaceutical Industries Limited |
Managing Director | NA |
NSE Symbol | SUNPHARMA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cipla | NA (0.00%) | 23.04 | ||
Dr Reddy's Laboratories | NA (0.00%) | 19.09 | ||
Mankind Pharma | NA (0.00%) | 55.15 | ||
Zydus Lifesciences | NA (0.00%) | 22.78 |